文献速递创伤骨科骨质疏松与代谢性骨病

多发性硬化患者的骨质疏松管理及继发性脆性骨折发生率:一项匹配队列研究

Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
PubMed 文献 · Osteoporos Int · 2022-06-07

该回顾性匹配队列研究基于PearlDiver数据库,纳入年龄≥50岁首次脆性骨折患者120,368例,其中多发性硬化(MS)患者1,232例按1:10匹配12,320例对照。MS组首次髋部脆性骨折比例显著更高(47.4% vs 34.2%,p<0.001),骨折后3年内跌倒率显著更高(27.8% vs 22.7%;OR 1.15;95%CI 1.01-1.32),但骨质疏松诊断率(12.9% vs 9.7%;OR 1.35;95%CI 1.13-1.61)和药物治疗率(14.4% vs 11.9%;OR 1.24;95%CI 1.04-1.46)也显著更高;继发性骨折率两组相当(6.3% vs 5.0%;OR 1.10;95%CI 0.85-1.40)。

要点

  • MS组首次髋部脆性骨折比例显著高于对照组(47.4% vs 34.2%,p<0.001)。
  • 骨折后3年,MS组跌倒率显著更高(27.8% vs 22.7%;OR 1.15;95%CI 1.01-1.32)。
  • MS组骨质疏松诊断与药物治疗率均显著更高,但继发性骨折率两组相当。

核心结论

  • 与匹配对照相比,多发性硬化患者首次髋部脆性骨折显著更常见。
  • 首次骨折后,多发性硬化患者跌倒率显著更高,但更可能被诊断为骨质疏松并接受药物治疗。
  • 继发性脆性骨折率两组相当(6.3% vs 5.0%;OR 1.10;95%CI 0.85-1.40)。

研究设计与样本

  • 回顾性匹配队列研究,使用PearlDiver数据库。
  • 纳入年龄≥50岁首次脆性骨折患者共120,368例。
  • 多发性硬化患者按1:10与对照匹配,匹配因素为年龄、性别和美国地区。
  • 骨折后3年通过逻辑回归比较骨质疏松诊断与药物治疗、低能量跌倒及继发性脆性骨折率。

主要发现

  • 多发性硬化组1,232例(平均年龄65.7岁),对照组12,320例(平均年龄65.8岁)。
  • 多发性硬化组首次髋部骨折比例显著高于对照组(47.4% vs 34.2%,p<0.001)。
  • 多发性硬化组骨质疏松诊断率显著更高(12.9% vs 9.7%;OR 1.35;95%CI 1.13-1.61)。
  • 多发性硬化组骨质疏松药物治疗率显著更高(14.4% vs 11.9%;OR 1.24;95%CI 1.04-1.46)。
  • 多发性硬化组跌倒率显著更高(27.8% vs 22.7%;OR 1.15;95%CI 1.01-1.32);继发性骨折率两组相当(6.3% vs 5.0%;OR 1.10;95%CI 0.85-1.40)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study highlights the persistent osteoporosis treatment gap following fragility fractures. Patients with multiple sclerosis sustained more primary hip fractures than controls and exhibited significantly higher rates of falls within three years post-fracture. However, multiple sclerosis (MS) patients were significantly more likely to be diagnosed with osteoporosis and treated with medications. INTRODUCTION: The purpose of this study was to compare rates of osteoporosis management, falls, and secondary fractures following primary fragility fractures among patients with MS versus matched controls. MATERIALS AND METHODS: A retrospective matched cohort study was conducted using the PearlDiver database. Patients aged ≥ 50 years with primary fragility fractures were identified (n = 120,368). Within this population, patients with MS were matched 1:10 with controls across age, sex, and US region. Rates of osteoporosis diagnoses and pharmacologic treatment, low-energy falls, and secondary fragility fractures were compared at three years post-fracture via logistic regression. RESULTS: A total of 1,232 patients with MS (mean age, 65.7 years) with primary fragility fractures were matched with 12,320 controls (mean age, 65.8 years). Primary hip fractures were significantly more common in the MS cohort (47.4% vs. 34.2%, p < 0.001). After the initial fracture, patients with MS were significantly more likely to receive a formal osteoporosis diagnosis (12.9% vs. 9.7%; OR 1.35; 95% CI, 1.13-1.61) and osteoporosis pharmacotherapy (14.4% vs. 11.9%; OR 1.24; 95% CI, 1.04-1.46). The MS cohort also exhibited significantly higher rates of falls (27.8% vs 22.7%; OR 1.15; 95% CI, 1.01-1.32). Rates of secondary fractures were comparable (6.3% vs. 5.0%; OR 1.10; 95% CI, 0.85-1.40). CONCLUSION: Primary hip fragility fractures were significantly more common in patients with MS compared to matched controls. Following an initial fracture, patients with MS exhibited a significantly higher rate of falls but were more likely to be diagnosed with osteoporosis and treated with medications.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Ross BJ, Ross AJ, Lee OC, et al. Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study. Osteoporos Int. 2022. PMID: 35670832. doi:10.1007/s00198-022-06451-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。